Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients >= 65 Years of Age: Results From Phase 2 and 3 Trials

Flamm, Steven L., Gane, Edward J., DuFour, Jean-Francois J., Rustgi, Vinod, Bain, Vincent G., Crawford, Darrell H., Andreone, Pietro, Hassanein, Tarek, Mazur, Wlodzimierz W., Lovell, Sandra S., Da Silva-Tillmann, Barbara, Shulman, Nancy, Puoti, Massimo, Box, Terry D. and Jacobson, Ira M. (2014). Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients >= 65 Years of Age: Results From Phase 2 and 3 Trials. In: Hepatology. 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston Ma, (1157A-1158A). Nov 07-11, 2014.

Author Flamm, Steven L.
Gane, Edward J.
DuFour, Jean-Francois J.
Rustgi, Vinod
Bain, Vincent G.
Crawford, Darrell H.
Andreone, Pietro
Hassanein, Tarek
Mazur, Wlodzimierz W.
Lovell, Sandra S.
Da Silva-Tillmann, Barbara
Shulman, Nancy
Puoti, Massimo
Box, Terry D.
Jacobson, Ira M.
Title of paper Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients >= 65 Years of Age: Results From Phase 2 and 3 Trials
Conference name 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases
Conference location Boston Ma
Conference dates Nov 07-11, 2014
Proceedings title Hepatology   Check publisher's open access policy
Journal name Hepatology   Check publisher's open access policy
Publication Year 2014
Sub-type Published abstract
ISSN 0270-9139
Volume 60
Start page 1157A
End page 1158A
Total pages 2
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: WoS Import
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 2 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 14 Dec 2014, 00:46:06 EST by System User